Diamedica Therapeutics Inc (DMAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 939 | 1,736 | 0 | 0 | 0 |
| Receivables | 60 | 52 | 0 | 0 | 0 |
| TOTAL | $1,051 | $1,854 | $0 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 19 | 19 | N/A | N/A | N/A |
| TOTAL | $19 | $19 | $N/A | $N/A | $N/A |
| Total Assets | $1,070 | $1,873 | $0 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,064 | 627 | 0 | 0 | 0 |
| TOTAL | $1,064 | $627 | $0 | $0 | $0 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,064 | $627 | $0 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,529 | N/A | N/A | N/A | N/A |
| Common Shares | 41,005 | 40,994 | 0 | 0 | 0 |
| Retained earnings | -48,016 | -46,707 | 0 | 0 | 0 |
| Other shareholders' equity | 765 | 749 | 0 | 0 | 0 |
| TOTAL | $5 | $1,246 | $0 | $0 | $0 |
| Total Liabilities And Equity | $1,070 | $1,873 | $0 | $0 | $0 |